StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) stock

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)

Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –

ANI Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ANI Pharmaceuticals's price to book ratio was 2.6× on Nov 11, 2026, against 3.4× a year earlier. Over the last 5 years it ranged from 1.1× to 4.2×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.6×−0.6
2025Dec 31, 20253.2×+0.5
2024Dec 31, 20242.6×+0.4
2023Dec 29, 20232.2×+0.2
2022Dec 30, 20222.0×−0.9
2021Dec 31, 20212.9×+1.1
2020Dec 31, 20201.8×−1.7
2019Dec 31, 20193.5×+0.8
2018Dec 31, 20182.7×−1.4
2017Dec 29, 20174.1×−0.0
2016Dec 30, 20164.1×+0.8
2015Dec 31, 20153.4×+0.9
2013Jan 31, 20132.4×+0.3
2012Dec 31, 20122.2×−3.9
2011Dec 30, 20116.0×−15.1
2010Dec 31, 201021.1×–

More ANI Pharmaceuticals figures

See a number that looks wrong?